We found that in 33 cancers, PLOD1 expression was negatively correlated with CD8+ T cells, B cells and CD4+ T cells, among others, and positively correlated with monocytes, macrophages, neutrophils and tumor-associated fibroblasts (CAFs). This evidence concerns the gene CD4 and cancer.